The government and the State Control Committee have
approved an action plan for 2024-2025 to improve the mechanisms of price
regulation in the field of paid medical services, to prevent unjustified price
increases for medicines and medical devices.
The plan provides for:
- adjustment of regulatory legal acts on the
establishment and application of maximum tariff limits for paid medical
services, formation of prices for medicines and medical devices;
- Strengthening control over the activities of private
health-care organisations and tightening licensing requirements for business
entities engaged in medical and pharmaceutical activities;
- taking other administrative and organisational
measures to improve price regulation and control in this area.
The main
objective of the joint action plan is to create mechanisms and control over the
formation by economic entities of reasonable prices for paid medical services,
medicines and medical devices, and to ensure their accessibility to the
population.